Bayer welcomed the decision by the Chemicals Regulation Directorate (CRD) to lift the restrictions on Bayer’s Iblon® broad-spectrum fungicide. The product which contains the active ingredient isoflucypram can now be applied to wheat and barley grown in the same field in successive esasons. The decision follows the successful submission and evaluation of additional data submitted by Bayer and reflects the the weight of evidence supporting the safety and efficacy of Iblon®. The CRD is part of Health & Safety Executive in the UK.
“This is good news for British growers, many of whom have come to appreciate the excellent broad-spectrum performance of Iblon®,” said Nils Bauer, Managing Director of Bayer’s Crop Science division in the UK. “The decision will allow growers to extend crop protection to successive crops grown in the same field and improve yield through extended crop greening, even where disease pressure is low. We hope soon to see this innovation also in the EU soon as until now Iblon® is only available to farmers in in Great Britian and New Zealand.”
The decision was communicated to Bayer at the same time that CRD also granted a label extension allowing for Vimoy® (Iblon®) to be used on barley, thereby expanding options for growers for the 2026 cropping season. Prior to October 2025, a maximum of 75g of Iblon® (isoflucypram) could be applied to a field every two years. At the minimum supported dose of 50g active substance per ha, this effectively limited its use to one application every two years.
Growers can now utilise the broad-spectrum efficacy of products containing Iblon® such as Vimoy® (Iblon®), Jessico® Fusion (Iblon® and Inatreq™ active (fenpicoxamid)), Plaxium® (Iblon® + prothioconazole + fluopyram), Caley® (Iblon® + prothioconazole), Ipresso® (Iblon® + prothioconazole), Resilis® (Iblon® + prothioconazole), Milteo® (Iblon® + prothioconazole), Scorpio® (Iblon® + prothioconazole) and Vivalis® (Iblon® + prothioconazole) on approved crops grown in the same field in successive seasons.